Acadia Pharmaceuticals | ACAD - Ebitda





Ebitda Veränderung Datum
Acadia Pharmaceuticals USD 40.99M 42.62M 2026-06
ALKERMES USD 120.06M 19.15M 2026-09
Alnylam Pharmaceuticals USD 360.27M 114.93M 2026-09
Biogen USD 450.8M 198.9M 2026-06
BioMarin Pharmaceutical USD 222.32M 76.27M 2026-06
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Cara Therapeutics USD -2.39M 3.16M 2025-03
Corcept Therapeutics USD 42.16M 91.17M 2026-06
Cytokinetics USD -160.3M 9.02M 2026-06
Eisai JPY 34.15B 34.48B 2026-06
Eli Lilly USD 9.46B 3.54B 2026-09
Incyte USD 778.57M 410.6M 2026-06
J&J USD 8.99B 721M 2026-06
Moderna USD -687M 571M 2026-06
Neurocrine Biosciences USD 375.3M 185.4M 2026-09
Pfizer USD 6.36B 350M 2026-09
Prothena USD -18.49M 44.46M 2026-06
PTC Therapeutics USD 161.9M 99.92M 2026-06
Sarepta Therapeutics USD -3.14M 33.31M 2026-09
Ultragenyx Pharmaceutical USD -61M 94M 2026-06
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06